NIH-Led Partnership to Accelerate Cancer Vaccine Development Expected to Launch in December

A new public-private cancer vaccine initiative led by the National Institutes of Health (NIH) is expected to launch in December, aiming to accelerate development of personalized cancer treatments.

Reported by The New York Times, the effort will bring together researchers, pharmaceutical and biotechnology companies, advocacy groups, nonprofits, and patients. The partnership follows a model similar to the collaboration that helped produce COVID-19 vaccines.

Unlike preventive vaccines, cancer vaccines target cancer cells in patients who already have the disease, highlighting a growing collaborative approach to advancing cancer treatment research and clinical development. Read more in Yahoo Finance here.